CD28 and cancer: The results demonstrated that these immune checkpoints are closely related to CCL26 expression in different cancers, namely CTLA4, LAG3, PDCD1, CD28, CD274, and TIGIT et al. exhibited a negative association with CCL26 in HNSC (Figure 5F).